This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada & Co.. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Don Nicholson: Innovator in Binding Assays
Introduction
Don Nicholson is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of binding assays for proteases and phosphatases. His innovative work has implications for various medical conditions, including diabetes and cancer.
Latest Patents
Don Nicholson holds a patent for a "Prosphatase binding assay." This patent discloses a binding assay designed for proteases and phosphatases that contain cysteine in their binding sites. The assay utilizes the nucleophilic properties of the sulfhydryl group in cysteine to determine the binding ability of new ligands against known enzyme inhibitors. By employing a mutant form of the enzyme, the assay effectively mitigates interference from oxidizing and alkylating agents, enhancing its reliability. This technology has important applications in drug discovery for diseases such as Alzheimer's and osteoporosis.
Career Highlights
Don Nicholson has had a distinguished career at Merck Frosst Canada & Co., where he has been instrumental in advancing research in enzymatic assays. His work has not only contributed to scientific knowledge but has also paved the way for new therapeutic approaches in medicine.
Collaborations
Throughout his career, Don has collaborated with esteemed colleagues, including Sylvie Desmarais and Michael Gresser. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Don Nicholson's contributions to the field of binding assays exemplify the impact of innovative thinking in biochemistry. His work continues to influence research and development in the medical field, showcasing the importance of patents in advancing scientific discovery.